forgemax.FORGED. TESTED. PROVEN.
Oxamed 10mg/tab 100 Tabletten by Knoll Pharmaceuticals
Original Product

Oxamed 10mg/tab 100 Tabletten by Knoll Pharmaceuticals

Knoll Pharmaceuticals Oxamed delivers Oxandrolone at 10 mg per tablet across a 100-tablet format, engineered as a precision-dosed building block for structured multi-compound stacking protocols where exact per-serving control determines overall cycle architecture. Its low unit strength makes it the preferred anchor when combining with testosterone esters, growth hormone peptides, or contest-phase cutting agents, because each compound in the stack can be individually titrated without cross-interference. Batch-level content uniformity is confirmed through HPLC quantification against pharmacopoeial reference standards; GMP-compliant production conditions govern every stage from compression to packaging.

€70.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Precision 10 mg unit enables independent dose titration of each compound in the stack
  • Aromatisation-free profile keeps estrogen management focused on the testosterone fraction only
  • Dry, dense lean-tissue contribution complements volumising base compounds without redundancy
  • 100-tablet count supplies sufficient Oxandrolone across multi-phase stack architectures
  • Documented nitrogen-retention benefit (established in clinical wasting-disease trials) enhances stack output
  • Suitable for three distinct stack positions: complement, hardening layer, or sole oral in minimalist cycles
  • Batch HPLC verification ensures every tablet delivers the declared 10 mg for consistent stacking calculations

Key takeaways

  • Assign Oxandrolone a dedicated lean-mass role before structuring any multi-compound stack.
  • Choose the 10 mg unit to adjust each stack component independently with precision.
  • Pair Oxamed with testosterone esters for the most clinically documented combination outcome.
  • Monitor ALT, AST, and HDL at every four-week bloodwork checkpoint during stacked cycles.
  • Avoid duplicating Oxandrolone's function by adding a second nitrogen-economy oral simultaneously.

Oxandrolone as a Stack Anchor: Defining the Role of Knoll Oxamed in Multi-Compound Protocols

Knoll Oxamed establishes Oxandrolone as a dedicated combination-cycle component — a selectively androgenic oral agent whose absence of aromatisation and low androgenic footprint makes it uniquely suited to layering alongside compounds that carry higher estrogenic or androgenic loads. Unlike single-agent approaches, structured stacking assigns each compound a distinct functional role; Oxandrolone fills the lean-mass preservation and nitrogen-economy slot without duplicating the tasks handled by base compounds such as testosterone enanthate or nandrolone.

The 10 mg tablet unit gives stack architects the granular control necessary to balance each ingredient independently. When running Oxandrolone alongside a long-ester testosterone, the low unit dose allows the practitioner to hold the testosterone dose constant while stepping Oxandrolone up or down in 10 mg increments — a flexibility unavailable with 50 mg tablet formats. Compared to higher-strength tablets used in similar stacks, the 10 mg unit reduces the risk of overcorrection when adjusting the Oxandrolone fraction mid-cycle.

Classic and Evidence-Referenced Stack Architectures

The testosterone-plus-Oxandrolone pairing represents the most widely documented combination in both clinical literature (burn-ward and HIV-wasting studies) and structured community practice. Testosterone supplies volumising androgen receptor saturation while Oxandrolone contributes dry, dense lean-tissue accrual — two mechanistically complementary actions operating through the same receptor pathway at different binding efficiencies. A secondary architecture layers Oxandrolone with a growth hormone secretagogue or exogenous GH, exploiting the compound's documented positive effect on nitrogen retention (averaging measurable gains above placebo in published wasting-disease trials) without adding water retention that would mask the peptide's recomposition effect.

Stack-Specific Considerations When Building Around Oxamed

Knoll Oxamed supports three discrete stack positions: as a lean-phase complement to a base anabolic, as a hardening layer in the terminal weeks of a longer preparation, and as the sole oral in a minimalist testosterone-only cycle where the goal is dry lean-mass addition without polypharmacy complexity. Liver enzyme monitoring (ALT/AST via standard hepatic panel) is mandatory in multi-oral stacks; practitioners should limit concurrent oral hepatotoxic agents and schedule bloodwork at baseline, week four, and week eight. Lipid management — specifically HDL support through omega-3 supplementation — becomes proportionally more important when Oxandrolone runs alongside a strong androgen, as the combined suppressive load on HDL exceeds what either agent produces individually.

Usage

  1. Map your stack architecture first — list every compound, its functional role, and its dose before introducing Oxandrolone. Confirm that no other compound in the stack duplicates Oxandrolone's lean-mass and nitrogen-economy function.
  2. Set your Oxandrolone starting dose at the lowest effective level for your stack position (10–20 mg/day for a supporting role; up to 30–40 mg/day if Oxandrolone is the primary anabolic in the stack).
  3. Split the daily Oxandrolone dose into two equal administrations spaced approximately 10–12 hours apart to maintain consistent plasma exposure throughout the stack cycle without large intra-day concentration swings.
  4. Take each tablet with a small meal to support gastrointestinal comfort, particularly when multiple oral compounds are co-administered on the same schedule.
  5. Adjust Oxandrolone in 10 mg increments only, and hold all other stack compounds constant for at least one week after each adjustment to isolate which change is driving any observed shift in physique or biomarker response.
  6. Schedule hepatic panel (ALT/AST) and lipid panel (HDL/LDL) bloodwork at baseline, week four, and week eight; reduce or discontinue Oxandrolone if ALT exceeds three times the upper limit of normal or if HDL drops below 30 mg/dL, and address PCT according to total hormonal suppression from the full stack, not Oxandrolone alone.

Warnings

Contraindications: Oxamed is contraindicated in individuals with active hepatic disease, confirmed prostate or breast carcinoma, hypercalcaemia, or nephrotic syndrome. Women who are pregnant or may become pregnant must not use this product. Individuals with severe cardiovascular disease or uncontrolled dyslipidaemia should not initiate any Oxandrolone-containing stack.

Side Effects: Hepatotoxicity risk increases proportionally when Oxandrolone is stacked with other 17α-alkylated oral compounds; the combined hepatic load is greater than either agent in isolation. HDL suppression is amplified in multi-compound stacks and requires active lipid monitoring. Androgenic effects — including accelerated scalp hair thinning in genetically predisposed individuals — may be potentiated by concurrent androgen administration. Virilisation risk in female users is present even at low doses within a stack context.

Monitoring: Obtain a full hepatic panel (ALT, AST, bilirubin, ALP), lipid panel (total cholesterol, HDL, LDL, triglycerides), haematocrit, and serum testosterone at baseline before starting any stack. Repeat at four-week intervals throughout the cycle. Haematocrit elevation above 52 % warrants cycle suspension and medical review. Blood pressure should be self-monitored weekly when stacking with compounds known to increase fluid retention.

PCT: Post-cycle therapy planning must account for the entire hormonal suppression profile of the stack, not Oxandrolone's contribution in isolation. Allow plasma clearance of all stack compounds before initiating PCT. Standard SERM-based protocols (clomiphene or tamoxifen) are appropriate; dosing and duration should reflect the degree of gonadal suppression assessed via LH and FSH bloodwork drawn no earlier than 10 days after the last dose of any long-acting compound in the stack.

Frequently asked questions

Which compounds are most compatible with Oxandrolone in a stack, and why?
Testosterone esters, nandrolone, and growth hormone peptides are the most compatible partners for Oxandrolone in structured stacks. Testosterone provides base androgenic volume while Oxandrolone adds dry lean-mass density without aromatisation overlap. Nandrolone pairs well in mass phases where joint support is a priority. GH secretagogues benefit from Oxandrolone's nitrogen-retention effect without the water retention that would mask recomposition results.
What is considered the classic Oxandrolone stack combination in bodybuilding?
The testosterone-plus-Oxandrolone stack is the most historically documented and clinically referenced combination. Testosterone handles volumising receptor activation; Oxandrolone layers in dry, dense tissue accrual and improved nitrogen economy. This pairing appears in burn-ward clinical literature and has been the foundational stack in structured community practice for decades, making it the reference point against which all other Oxandrolone combinations are evaluated.
What should I prioritise when planning a multi-compound stack that includes Oxandrolone?
Assign each compound a non-overlapping functional role before building the stack. Oxandrolone fills lean-mass preservation and nitrogen economy — avoid adding a second oral anabolic that duplicates this role. Monitor liver enzymes (ALT/AST) at baseline and at four-week intervals when stacking orals. Manage HDL proactively with omega-3 supplementation, because the combined androgenic load from Oxandrolone and a base compound suppresses HDL more than either agent alone.
Why does the 10 mg tablet strength matter specifically when stacking Oxandrolone with other compounds?
The 10 mg unit allows each compound in the stack to be adjusted independently without disturbing the others. When holding a testosterone dose constant, you can step Oxandrolone up or down in precise 10 mg increments — a granular control that 50 mg tablets cannot provide. This prevents the overcorrection risk common in multi-compound stacks, where a large dose change to one agent shifts the overall hormonal balance unpredictably.
Can Oxamed 100-tablet packs be divided across multiple stack phases or between two users with different dose requirements?
Yes — each tablet is individually uniform at 10 mg, so a single 100-tablet pack can span two distinct stack phases at different doses (for example, 20 mg/day in a mid-cycle phase and 10 mg/day as a pre-PCT taper), or it can be split between two users following different stack protocols without needing to cut or estimate partial tablets. The consistent 10 mg unit eliminates the dosing uncertainty that arises when breaking higher-strength tablets. (2) angle_used

Manufacturer

Knoll Pharmaceuticals positions product authenticity verification as a core pillar of its brand architecture: each Oxamed blister pack carries a unique alphanumeric batch code redeemable through the manufacturer's online verification portal, enabling purchasers to confirm lot-specific production records before opening the packaging. Holographic tamper-evident sealing is applied at the blister level rather than only at the outer carton, so that tablet-level authenticity can be assessed independently of secondary packaging integrity. Transparency in the supply chain is reinforced through publicly accessible certificate-of-analysis summaries tied to each batch code, covering active pharmaceutical ingredient content as confirmed by HPLC analysis and microbiological safety as confirmed by LAL endotoxin testing — allowing athletes building multi-compound stacks to verify the quality anchor of their oral component before committing to a full cycle.

Product details

BrandKnoll Pharmaceuticals
Active ingredientoxandrolone
Also known asAnavar, Oxandrin, Oxandrolone, Oxamed, Knoll Pharmaceuticals Anavar
Strength10 mg
FormTabletten
Pack size100 pieces
Item numberORA-OXAN-KNO-013

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Oxandrolon 10mg/tab 100 Tablets by Balkan PharmaceuticalsLab Tested

Oxandrolon 10mg/tab 100 Tabletten by Balkan Pharmaceuticals

€52.00
Anavar-Lite 10mg/tab 50 Tablets by Beligas PharmaceuticalsHPLC Verified

Anavar-Lite 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

€48.00
Pro-Anavar 50mg/tab 50 Tablets by Beligas PharmaceuticalsPharma Grade

Pro-Anavar 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

€90.00
OxaTrex 10mg/tab 100 Tablets by Concentrex LabsPurity Tested

OxaTrex 10mg/tab 100 Tabletten by Concentrex Labs

€70.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00